Evaluating the effectiveness of a novel cost-effective aerosol containment chamber for high-risk autopsies: a pilot study.

Publication date: Jul 02, 2025

Autopsy personnel face substantial occupational risks from exposure to infectious agents, particularly during aerosol-generating procedures like bone sawing. The COVID-19 pandemic highlighted these dangers, underscoring the need for innovative safety solutions in resource-limited settings without negative-pressure autopsy suites. To address this, we developed a Low-Cost Infection Containment Chamber (LCICC)-a full-length, transparent, and impermeable structure designed to contain aerosols during high-risk autopsy procedures. This study evaluated the efficacy of LCICC using goat skulls to simulate aerosol generation during sawing. Aerosol densities were measured under both open-air conditions and with LCICC use, employing fluorescein dye for visualization and particle counter for quantification. Statistical analysis confirmed the chamber’s effectiveness in reducing occupational exposure. LCICC demonstrated a substantial reduction in aerosol levels, ranging from 85. 96 to 88. 38% across all particle sizes. Median aerosol densities were consistently recorded at 10. 50 mg/m^3 with LCICC use, compared to 74. 80 to 90. 40 mg/m^3 in open-air conditions. LCICC’s affordability, ease of assembly, and reliable performance position it as a groundbreaking tool for protecting healthcare workers, particularly in low-resource settings. This innovation addresses critical gaps in autopsy safety protocols, offering a practical solution to mitigate risks associated with infectious aerosols while advancing occupational health standards in forensic pathology.

Open Access PDF

Concepts Keywords
50mg Aerosol containment
Affordability Aerosols
Autopsy Aerosols
Goat Animals
Pilot Autopsy
Autopsy safety
Cost-Benefit Analysis
COVID-19
COVID-19
Goats
Humans
Infection control
Infectious diseases
Occupational Exposure
Occupational health
Particle Size
Pilot Projects
SARS-CoV-2

Semantics

Type Source Name
disease MESH COVID-19 pandemic
disease MESH Infection
drug DRUGBANK Medical air
drug DRUGBANK Fluorescein
drug DRUGBANK Dihydrotachysterol
disease MESH Infectious diseases
disease IDO blood
disease IDO object
disease MESH death
drug DRUGBANK Coenzyme M
disease IDO history
disease IDO process
disease IDO production
disease MESH hypersensitivity
disease MESH hospital infection
drug DRUGBANK Iron
disease IDO site
drug DRUGBANK Water
disease MESH Infectious Disease Transmission Patient-to-Professional

Original Article

(Visited 2 times, 1 visits today)